The effect of carotid stenting on rheological parameters, free radical production and platelet aggregation

Clinical Hemorheology and Microcirculation

Volumn 43, Issue 3, 2009, Pages 209-217

  Szapary, L ^a   Bagoly, E ^a   Kover, F ^a   Feher, G ^a   Pozsgai, E ^a   Koltai, K ^a   Hanto, K ^a   Komoly, S ^a   Doczi, T ^a   Toth, K ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Carotid stenting; Oxidative stress; Platelet aggregation; Rheology

Indexed keywords

ACETYLSALICYLIC ACID; CATALASE; CLOPIDOGREL; FIBRINOGEN; FREE RADICAL;

ADULT; ARTICLE; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE AGGREGATION; FEMALE; FIBRINOGEN BLOOD LEVEL; FLOW KINETICS; HEMATOCRIT; HUMAN; LOADING DRUG DOSE; MALE; OXIDATIVE STRESS; PLASMA VISCOSITY; RESTENOSIS; STENT; THROMBOCYTE AGGREGATION;

AGED; CAROTID ARTERIES; CAROTID STENOSIS; FEMALE; FREE RADICALS; HEMATOCRIT; HEMORHEOLOGY; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; RHEOLOGY; RISK FACTORS; STENTS;

EID: 70350455294     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: 10.3233/CH-2009-1210     Document Type: Article

References (32)

1. T. Thom, N. Haase, W. Rosamond et al., Heart disease and stroke statistics - 2006 update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee, Circulation 113(6) (2006), e85-e151.
2. Antiplatelet Trialists, Collaboration. Collaborative overview of randomized trials of antiplatelet therapy: 1. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients, BMJ 308 (1994), 81-106.
3. L. Szapary, B. Horvath, Z. Marton et al., Hemorheological disturbances in patients with chronic cerebrovascular diseases, Clin. Hemorheol. Microcirc. 31(1) (2004), 1-9.
4. M. Fisher, J. Herbert and J. Meiselman, Hemorheological factors in cerebral ischemia, Stroke 22 (1991), 1164-1169.
5. E. Ernst, A.Matrai and M. Marshal, Blood rheology in patients with transient ischemic attacks, Stroke 19 (1988), 634-636.
6. I.G. Szirmai, A. Kamondi, H.Magyar et al., Relation of laboratory and clinical variables to the grade of carotid atherosclerosis, Stroke 24 (1993), 1811-1816.
7. G. Késmárky, K. Tóth, G. Vajda et al., Hemorheological and oxygen free radical associated alterations during and after percutaneous transluminal coronary angioplasty, Clin. Hemorheol. and Microcirc. 24 (2001), 33-41.
8. B. Van der Loo, T. Kovacevic, E. Krieger et al., Blood fluidity and outcome after femoropopliteal percutaneous transluminal angioplasty (PTA): Role of plasma viscosity and low platelet count in predicting restenosis, Clin. Hemorheol. Microcirc. 32 (2005), 159-168.
9. C.V. Serrano, J.A. Ramires, M. Venturinelli et al., Coronary angioplasty results in leukocyte and platelet activation with adhesion molecule expression. Evidence of inflammatory responses in coronary angioplasty, J. Am. Coll. Cardiol. 29 (1997), 1276-1283.
10. G.S. Oostenbrug, R.P. Mensink, F.W. Bar et al., Lipid peroxidation-associated oxidative stress during percutaneous transluminal coronary angioplasty in humans, Free Radic. Biol. Med. 22 (1997), 129-136.
11. P.K. Shah, Inflammation, neointimal hyperplasia, and restenosis. As the leukocytes roll, the arteries thicken, Circulation 107 (2003), 2175-2177.
12. F. Krotz, H.Y. Sohnsnd U. Pohl, Reactive oxygen species: players in the platelet game, Arterioscler. Thromb. Vasc. Biol. 24 (2004), 1988-1996.
13. Y. Taniyama and K.K. Griendling, Reactive oxygen species in the vasculature: molecular and cellular mechanisms, Hypertension 42 (2003), 1075-1081.
14. A. Clauss, Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens, Acta Haematol. 17 (1957), 237-246.
15. K. Toth, E. Ernst, T. Habon et al., Hemorheological and hemodynamical effects of fish oil (Ameu) in patients with ischemic heart disease and hyperlipoproteinemia, Clin. Hemorheol. 15 (1995), 867-875.
16. H.J. Klose, E. Volger, H. Brechtelsbauer, L. Heinich and H. Schmid-Schonbein, Microrheology and light transmission of blood, Pflug. Arch. 333 (1972), 126-139.
17. K. Toth, R.B. Wenby and H.J. Meiselman, Inhibition of polymer-induced red blood cell aggregation by poloxamer 188, Biorheology 37 (2000), 301-312.
18. Z. Marton, R. Halmosi, B. Horvath et al., Scavenger effect of experimental and clinically used cardiovascular drugs, J. Cardiovasc. Pharmacol. 38 (2001), 745-753.
19. H. Aebi, Catalase in vitro, Methods Enzymol. 105 (1984), 121-126.
20. R.F. Beers and I.W.J. Sizer, Spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase, Biol. Chem. 195 (1952), 133-140.
21. J.A. Chesebro, J.Y.T. Lam, L. Badimon et al., Restenosis after arterial angioplasty: a hemorrheologic response to injury, Am. J. Cardiol. 60 (1987), 748-756.
22. J.F. Price, N. Mamode, F.B. Smith et al., Haemostatic and rheological factors as predictors of restenosis following percutaneous transluminal angioplasty, Eur. J. Vasc. Endovasc. Surg. 14 (1997), 392-398.
23. M. Schillinger, M. Exner, W. Mlekusch et al., Acute-phase response after stent implantation in the carotid artery: association with 6-month in-stent restenosis, Radiology 227 (2003), 516-521.
24. B. Symonides, A. Januszewicz, O. Rowinski et al., Plasma fibrinogen as a risk factor for restenosis after percutaneous transluminal renal angioplasty in patients with atherosclerotic renal artery stenosis, J. Cardiovasc. Risk 6 (1999), 269-272.
25. G. Montalescot, A. Ankri, E. Vicaut et al., Fibrinogen after coronary angioplasty as a risk factor for restenosis, Circulation 92 (1995), 31-38.
26. R. Kornowski, M.K. Hong, F.O. Tio et al., In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia, J. Am. Coll. Cardiol. 31 (1998), 224-230.
27. S.M. Schwartz, L. Foy, D.F. Bowen-Pope et al., Derivation and properties of platelet-derived growth factor-independent rat smooth muscle cells, Am. J. Pathol. 136 (1990), 1417-1428.
28. P.A. Gurbel and K.P. Bliden, Platelet activation after stenting with heparincoated versus noncoated stents, Am. Heart J. 146 (2003), E10.
29. E. Atalar, K. Aytemir, I. Haznedaroglu et al., Platelet and leukocyte deactivation after intracoronary stent placement in patients receiving combined antiplatelet therapy, Clin. Appl. Thromb. Hemost. 7 (2001), 116-121.
30. J. Fingerle, R. Johnson, A.W. Clowes et al., Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery, Cell Biol. 86 (1989), 8412-8416.
31. I. Moussa,M. Oetgen, G. Roubin et al., Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation, Circulation 99 (1999), 2364-2366.
32. A.B. Bridges, N.A. Scott, T.H. Pringle et al., Relationship between the extent of coronary artery disease and indicators of free radical activity, Clin Cardiol. 169 (1992), 174.